Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Data Inclusion | Other | Patients in this group will be included in the project |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with major Adverse Kidney Events | death from any cause, new renal replacement therapy or persistent renal dysfunction | within 30 days or at hospital discharge |
| LR IV Fluids administered | Proportion of LR IV fluids following implementation | Through study completion (an average of 1 year) |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of hospital admission and readmission | Within 30 days of initial ED encounter | |
| Cost | Direct costs of ED care and hospitalization | Through study completion (an average of 1 year) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Data to determine study outcomes will be extracted from the EDW and stored in a secure database. No actualy contact with patients will take place for this data-only study
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Intermountain Medical Center | Murray | Utah | 84157-7000 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided